Microbot Medical AI Stock Analysis
Microbot Medical (MBOT) AI Stock Analysis
Microbot Medical
(NASDAQ:MBOT)
No summary available
Microbot Medical (MBOT) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $46.28M
- Dividend Yield
- ―
- Average Volume (3M)
- 880.00K
- Price to Earnings (P/E)
- -2.5
- Beta (1Y)
- 1.30
- Revenue Growth
- ―
- EPS Growth
- 38.89%
- Country
- US
- Employees
- 43
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Microbot Medical Business Overview & Revenue Model
Company Description
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive p...
Microbot Medical Risk Analysis
Microbot Medical disclosed 46 risk factors in its most recent earnings report. Microbot Medical reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
2 New RisksMicrobot Medical Peers Comparison
Overall Rating
INFU70Outperform
KRMD57Neutral
MLSS44Neutral
FEMY43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | $296.30M | 31.61 | 15.77% | ― | 2.40% | 76.01% | |
| 57Neutral | $151.38M | -195.48 | 0.00% | ― | 18.43% | 78.07% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | $25.10M | -6.67 | -122.29% | ― | 3.93% | 48.18% | |
| 43Neutral | $9.70M | -0.36 | -114.48% | ― | -4.21% | 78.58% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MBOT | Microbot Medical | 0.69 | -1.04 | -60.17% | |
| INFU | InfuSystem Holdings, Inc. | 14.79 | 5.57 | 60.41% | |
| MLSS | Milestone Scientific Inc | 0.28 | -0.03 | -9.18% | |
| KRMD | Repro-Med Systems, Inc. | 3.49 | -0.91 | -20.68% | |
| FEMY | Femasys, Inc. | 1.12 | -14.89 | -93.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
